This inventor holds 4 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Celldex Therapeutics Limited. Active years: 2020-2025.
Company Filing History:
Years Active: 2020-2025
Title: The Innovative Contributions of Jenifer Widger
Introduction
Jenifer Widger is a prominent inventor based in Alpha, NJ (US), known for her significant contributions to the field of immunology. With a total of four patents to her name, she has made remarkable strides in developing therapeutic and diagnostic methods that utilize monoclonal antibodies.
Latest Patents
Among her latest patents are innovative agonistic antibodies that bind to human CD40. These isolated monoclonal agonistic antibodies and related antibody-based compositions are designed for various therapeutic and diagnostic applications. The patents also detail methods for inducing or enhancing an immune response through the administration of these agonistic anti-CD40 antibodies.
Career Highlights
Jenifer Widger is currently associated with Celldex Therapeutics Limited, where she continues to advance her research and development efforts. Her work focuses on creating effective treatments that leverage the immune system's capabilities to combat diseases.
Collaborations
Throughout her career, Jenifer has collaborated with notable colleagues, including Tibor P Keler and Joel Goldstein. These partnerships have further enriched her research and contributed to the success of her innovative projects.
Conclusion
Jenifer Widger's contributions to the field of immunology through her patents and collaborative efforts highlight her role as a leading inventor. Her work continues to pave the way for advancements in therapeutic and diagnostic methods, showcasing the impact of innovation in healthcare.